Insight into the Interaction Mechanism of Nicotine, NNK, and NNN with Cytochrome P450 2A13 Based on Molecular

Jorddy Neves Cruz1,2, Mozaniel Santana de Oliveira1, Sebastião Gomes Silva1

  • 1Adolpho Ducke Laboratory , Emílio Goeldi Paraense Museum , Belém , Pará 66040-170, Brazil.

Insights

Cytochrome 2A13 metabolizes tobacco carcinogens like NNK and NNN. Molecular dynamics simulations reveal how these substrates bind, with asparagine 297 crucial for catalysis, offering new insights into tobacco-related cancer mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Tobacco smoke contains carcinogens like nicotine, NNK, and NNN.
  • Cytochrome 2A13 activates these pro-carcinogens via α-hydroxylation.
  • The precise mechanism of cytochrome 2A13 substrate interaction is not fully understood.

Purpose of the Study:

  • To analyze the conformational dynamics of cytochrome 2A13 during substrate interaction.
  • To elucidate the molecular basis of substrate binding and activation.
  • To provide mechanistic insights into the α-hydroxylation of tobacco carcinogens.

Main Methods:

  • Molecular dynamics (MD) simulations
  • Principal Component Analysis (PCA)
  • Free energy calculations (MM/GBSA)

Main Results:

  • Identified essential protein motions governing substrate interaction.
  • Highlighted the critical role of asparagine 297 in maintaining catalytic orientation via hydrogen bonding.
  • Observed distinct conformational dynamics for nicotine/NNK versus NNN interactions.

Conclusions:

  • Elucidated the conformational mechanism of cytochrome 2A13 in metabolizing tobacco carcinogens.
  • Revealed substrate-specific interactions within the active site.
  • Provided a molecular basis for understanding tobacco carcinogen activation and developing targeted interventions.

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.2K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
16.1K
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview01:25

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
295
Nonlinear Pharmacokinetics: Michaelis-Menten Equation01:18

Nonlinear Pharmacokinetics: Michaelis-Menten Equation

The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
954